Apoptosis, the process whereby cells activate an intrinsic death program, can be induced in HeLa cells by TNF-a treatment. The aims of the present study were (i) to examine the precise role and the origin of Reactive Oxygen Species (ROS) in the TNF-a-induced programmed cell death, (ii) to characterize and order the morphological and mitochondrial changes associated with this process and (iii) to link these events with the activation of caspases. Analyses were performed on TNF-a-treated cells in the presence of an anti-oxidant, or of a general caspase inhibitor. To assess the role of mitochondria in the cell death signal transduction, these studies were also realized on HeLa-variant cell lines lacking functional mitochondrial respiratory chain. We show that at least two separate signaling cascades, both mediated by Z-VAD-sensitive caspase(s), contribute to the TNF-a-induced apoptosis of HeLa cells. One signaling pathway involves an early mitochondriadependent ROS production, the other being ROSindependent.
Introduction
Programmed cell death (PCD), also known as apoptosis, the process whereby cells activate an intrinsic death program, is a critical element in the repertoire of potential cellular responses, as are cell dierentiation or proliferation. All nucleated mammalian cells, both in developing and mature organs, are able to undergo PCD and constitutively express all the protein components required to execute the death program, which are normally suppressed by extracellular survival signals. Moreover, it seems that new macromolecular synthesis, when necessary for PCD, contributes to the activation rather than to the execution of the death program (Ra, 1992; Weil et al., 1996) .
The programmed cell death cascade can be conveniently divided into several phases. During the activation phase, multiple signaling pathways, initiated by the various death-triggering signals, lead to the central control of the cell death machinery and activate it. This is followed by the execution stage, in which the activated machinery acts on multiple cellular targets, and, ®nally, the destruction phase in which the dead or dying cell is broken down.
A most important clue to the molecular nature of the death program came initially from genetic studies in C. elegans that led to the identi®cation of a dozen cell death genes (ced) that are responsible for one aspect or another of cell death processes (Ellis et al., 1991) . Three of these genes stand out. Two of them, ced-3 and ced-4 are required to execute the cell death program. The third one, ced-9, antagonizes the death activities of ced-3 and ced-4. Moreover, genetically, ced-4 has been placed between ced-9 and ced-3 in the pathway leading to cell death (Shaham and Horvitz, 1996) . Spectacular progress arose with their cloning, when it became clear that they encoded components of a universal and highly conserved death machinery. CED-3 protein turned out to be a member of a family of cysteine proteases, known as caspases (Yuan et al., 1993) . The mammalian caspase family now comprises at least ten known members, most of which have been de®nitively implicated in PCD (Duan et al., 1996; Fraser and Evan, 1996; McCarthy et al., 1997) . Caspases mediate PCD by cleaving selected intracellular proteins, including proteins of the nucleus, nuclear lamina, cytoskeleton, endoplasmic reticulum and cytosol.
CED-9 protein is homologous to a family of many members termed the Bcl-2 family (Reed, 1997) . Some members, such as Bcl-2 or BCl-x L , inhibit PCD, whereas others, such as Bax and Bik, promote cell death. The various family members (referred to here as Bcl-2s), which are primarily localized to intracellular membranes, can dimerize with one another, with one monomer antagonizing or enhancing the function of the other (Korsmeyer, 1995) . Recent reports have shown that, in both worm and mammalian cells, the anti-apoptotic Bcl-2s act upstream of the`execution caspases' somehow preventing their proteolytic processing into active killers (Shaham and Horvitz, 1996; Golstein, 1997) . Two main mechanisms of action have been proposed to connect Bcl-2s to caspases. In the ®rst one, anti-apoptotic Bcl-2s would maintain cell survival by dragging CED-4 or CED-4 like/caspase complexes to intracellular membranes, keeping them in an inactive conformation and in this way preventing their activation (Chinnaiyan et al., 1997; Wu et al., 1997) . In the second model, Bcl-2s would also act by regulating the release of some caspase activators, as cytochrome c or Apoptosis Inducing Factor (AIF), usually sequestered in intracellular compartments Kluck et al., 1997; Yang, et al., 1997) . The observed pore-forming properties of some Bcl-2s suggest that these products would directly regulate the permeability of the intracellular mem-branes (Muchmore et al., 1996; Minn et al., 1997; Schendel et al., 1997) .
Given the complexity and diversity of caspase activation pathways, these experiments point to the mitochondrion as an unifying element of PCD (Golstein, 1997; Kroemer et al., 1997; Reed, 1997; Mignotte and VayssieÁ re, 1998) . Although for a long time the absence of mitochondrial changes was considered as a hallmark of apoptosis, mitochondria appear today as the central executioner of programmed cell death. Several reports suggest that mitochondria could be a crucial target in the apoptotic process, a point-of-no-return where dierent signal transduction pathways converge and beyond which a cell becomes irreversibly committed to death. Impairment in rnitochondrial function, an early event in the executive phase of PCD in dierent cell types, appears as the consequence of a preliminary reduction of the mitochondrial transmembrane potential (DCm) (VayssieÁ re et al., 1994; Petit et al., 1995; Zamzami et al., 1995) . The early DCm disruption would be the result of an opening of mitochondrial permeability transition pore (PTP) and this permeability transition would trigger the release of apoptogenic factors, as AIF or cytochrome c, capable of inducing the later apoptotic events Zamzami et al., 1996) .
This crucial position of mitochondria in PCD control is reinforced by results suggesting a more upstream involvement of mitochondria in PCD via the production of cell death signaling Reactive Oxygen Species (ROS). Indeed, several observations outline that these compounds may be central in the cell death transduction pathways of PCD triggered by a wide range of in¯uences including UV light, ionizing irradiation, anthracyclines, ceramides, glucocorticoids or survival-factor withdrawal (Jacobson, 1996) . In particular, the ability of endogenous or exogenous anti-oxidants to inhibit or delay PCD in some experimental systems appears as one of the compelling evidences of the contribution of ROS to the activation of the execution machinery (Wong, 1989; Sandstrom and Buttke, 1993; Mayer and Noble, 1994; Greenlund et al., 1995; Mehlen et al., 1996) . The nature of the ROS involved in PCD is a con¯icting question. Indeed, two opposite models have emerged in relation with the variety of metabolic reactions and intracellular sites which can generate ROS (Jacobson, 1996) . While most investigators believe that oxidants are produced by electron chain transport, some data suggest that fatty acid metabolites, such as those produced from arachidonic acid by the lipoxygenase pathway, may be better mediators of PCD (O'Donnell et al., 1995) . Nevertheless, these considerations do not refute the mounting evidence of the involvement of the mitochondrial electron transport chain in PCD-signaling ROS production. Thus, it was established that both ROS accumulation and PCD process require the presence of a functional mitochondrial respiratory chain in most ROS-dependent cell death systems (Schulze-Ostho et al., 1993; Higuchi et al., 1997; Quillet-Mary et al., 1997) .
To date, most of the progress in understanding PCD has been horizontal. However, major challenges remain in linking these expanding knowledges to integrate this pathway vertically. Of particular relevance would be insights into the connections between the molecular components involved in PCD and the physiological and morphological events associated with cell death. We have used the Tumor Necrosis Factor-a (TNF-a)-mediated cytotoxicity as a model for such an approach according to the data that outline the involvement of mitochondria, ROS and caspases in this cell death type.
One of the prominent features of this cytokine is its ability to kill several cell lines. Depending on the celltype, TNF-a can induce both necrosis and PCD through complex signal transduction cascades initiated by the occupancy of the cell surface receptor TNFR1, and multiple intracellular pathways may be involved (Liu et al., 1996b) . ROS appear as potent mediators of the killing activity of the cytokine (Goossens et al., 1995; Talley et al., 1995) . The protective eect exerted by inhibitors or by elimination of the mitochondrial electron transport chain suggests that mitochondria could be the source of ROS production (SchulzeOstho et al., 1992 (SchulzeOstho et al., , 1993 . However, some other data provide evidence that the lipoxygenase pathway rather that the mitochondrial respiratory chain plays a central role in TNF-a-mediated cytolysis (O'Donnell et al., 1995) . However, most of the data showing a requirement for ROS production in cell death activation would concern necrosis rather than PCD. It was assumed that TNF-a induces ROS formation and PCD by separate pathways, and that the ROS produced can lead to necrosis depending on other signals, intracellular redox status and levels of antioxidant protection (Jacobson, 1996) . Thus, accumulation of high levels of ROS would induce necrosis, while PCD would be predominant in the presence of low levels of ROS.
A major advance in understanding early events in TNF-a signaling was the identi®cation of proteins (TRADD, FADD and RIP) that are recruited to the cytoplasmic domain of TNFR1, following ligand induced trimerization (Nagata, 1997) . Two death pathways have been identi®ed: one mediated via FADD-induced recruitment of caspase-8, originally termed MACH/FLICE (Boldin et al., 1996) and the other linked to RIP and the possible recruitment, via its death domain, of another downstream eector molecule (Stanger et al., 1995; Boldin et al., 1996; Nagata, 1997) . Caspase-8 could connect this complex and the cell death machinery, and so could be the most upstream enzymatic component in the TNF-a-induced cell death signaling cascades (Boldin et al., 1996) . Other members of the caspase family, such as caspase-7 and caspase-3, could be substrates for caspase-8 cleavage. Involvement of multiple proteases in the cell death process is consistent with the reported ability of inhibitors of distinct caspases to protect cells from TNF-a-induced cell death (Beidler et al., 1995; Hsu et al., 1995; Miura et al., 1995; Duan et al., 1996) .
The aims of the present study were (i) to examine the precise role and the source of ROS in the TNF-ainduced PCD, (ii) to characterize and order the morphological and mitochondrial changes associated with this process and (iii) to link these events with the activation of caspases. For this purpose, we monitored, by¯ow cytometry, the mitochondrial membrane potential and ROS formation in individual TNF-atreated HeLa cells. Analyses were also performed on TNF-a-treated cells in the presence of an anti-oxidant, TNF-a activates at least two apoptotic cascades C Sidoti-de Fraisse et al Figure 1 Morphological features of E/TNF induced HeLa cell death. Photographs of culture dishes were taken with a phase contrast microscope (scale bar equals 100 mm), after 6 h of emetine or E/TNF treatment. Pictures of cells treated with E/ TNF in the presence of an anti-caspases (100 mM Z-VAD) or an anti-oxidant (100 mM BHA) are also included. The histogram reports the percentage of cell death obtained after 14 h of indicated treatment, assessed by trypan blue dye exclusion test TNF-a activates at least two apoptotic cascades C Sidoti-de Fraisse et al or of a general caspase inhibitor. To assess the role of mitochondria in the cell death signal transduction, these studies were also realized on HeLa-variant cell lines lacking functional mitochondrial respiratory chain. We show that at least two separate signaling cascades, one ROS-dependent and the other ROSindependent, contribute to the TNF-a-induced PCD of HeLa cells. ROS generation, an upstream event in the cell death process, requires functional mitochondria and is dependent on activation of caspase(s).
Results

TNF-a induces apoptosis in HeLa cells
TNF-a is a cytokine that causes in vitro cell death of several transformed cells. Depending on the cell type, TNF-a kills either by necrosis or apoptosis (SchulzeOstho et al., 1994) . HeLa cells are resistant to cytolysis by TNF-a but can be sensitized by inhibition of protein synthesis. In order to characterize the pattern of HeLa cell death induced by TNF-a plus emetine as macromolecular synthesis inhibitor, we have analysed cytological alterations and DNA fragmentation upon treatment. The earliest changes observed were rounding up, phase-brightening and shrinkage of cells and blebbing of the plasma membrane ( Figure 1 ). These events were observed after 4 h of treatment and preceded detachment, loss of refringence of the cells as well as fragmentation of DNA, as judged by¯ow cytometric analysis of TUNEL-stained cells (data not shown). These alterations massively occurred after 9 h of incubation with the drugs. Breaking up of the dead cells into fragments was the latest event observed, but it aected only few dead cells. All these morphological and molecular changes are characteristic features of apoptosis (Kerr et al., 1972) . This morphological study as well as the following experiments were also performed in the presence of a synthetic caspases inhibitor or in the presence of an anti-oxidant. To avoid redundancy, the eects of these compounds will be presented in speci®c paragraphs.
A two-step process in ROS generation is associated with TNF-a-induced apoptosis
In order to assess ROS production in individual cells during apoptotic cell death induced by TNF-a,¯ow cytometric analysis was carried out using DCFH-DA as uorescent probe (see Material and methods). In parallel, with the aim to compare the kinetic of changes in ROS production to the evolution of a well established early hallmark of apoptosis, a similar study was performed concerning the DCm, using DiOC 6 (3) as uorochrome (VayssieÁ re et al., 1994; Petit et al., 1995; Zamzami et al., 1995) . In all measures, cell plasma membrane integrity was also assessed by staining cells with PI (see Materials and methods). A two-step process was observed concerning the evolution of DiOC 6 (3) and DCF¯uorescences during E/TNF treatment (see Figure 2 , cytograms FSC versus DiOC 6 (3) or DCF). Indeed, for each staining, two new cell clusters successively appeared after E/TNF addition. For DiOC 6 (3)¯uorescence, a fraction of cells underwent a ®rst reduction in tracer retention as compared to control cells, immediately followed by a second decrease. These populations have been classi®ed as follows: (i) DiOC-medium cells are cells with intermediate loading (four times less than control cells) and (ii) DiOC-low, cells are cells presenting the lowest staining (thirty times less than control cells). Conversely, for DCF¯uorescence, a fraction of cells presented a ®rst increase in DCF production (three times more than untreated cells) followed by a second higher increase in DCFH-DA oxidization (ten times more than untreated cells). These populations are respectively named DCF-medium and DCF-high cells. Figure 3 shows the evolution of the percentages of these distinct cell populations during the E/TNF treatment. From data plotted on the upper panel, it appears that globally, the percentages of DiOC 6 (3)-negative cells (sum of DiOC-medium and -low cells) and DCF-positive cells (sum of DCF-medium and -high cells) evolve identically during E/TNF treatment. Analysis of the stack histograms ( Figure 3 , middle and lower panels) detailing the respective part of DiOC 6 (3)-medium and -low cells (or DCF-medium and -high cells) to the global percentage of DiOC 6 (3)-negative (or DCF-positive) cells appearing during treatment has led to the following conclusions: (i) the appearance of DCF-medium cells corresponding to the ®rst increase in ROS production was correlated with the appearance of DiOC-medium cells that result from the ®rst drop of DCm; (ii) the second fall of DCm arose immediately after the ®rst one in such a way that it appeared as the consequence of a magni®cation process; (iii) the second burst in ROS production giving DCF-high cells was clearly time distinct from the ®rst increase and followed the second loss of DCm leading to DiOClow cells; (iv) the TNF-a-induced responses evolve asynchronously in the cell population.
These¯ow cytometric data were performed on whole cell population, i.e. adherent but also¯oating cells (not visible before 9 h of treatment). At this time, separate analysis of adherent and¯oating cells showed that while all¯oating cells demonstrated higher DCF uorescence and lower DiOC 6 (3)¯uorescence, only some adherent cells presented these features (data not shown). Thus, the appearance of DiOC-low and DCFhigh¯uorescences preceded detachment and loss of the refringence of the E/TNF treated cells that characterize the destruction phase of the process.
In view of these results, we investigated the relationship between these changes and morphological events associated with the cell death process. At dierent time points, E/TNF-treated cells were double-loaded with either DiOC 6 (3)/DAPI or DCFH-DA/DAPI and examined by epi¯uorescence. After 4 h of E/TNF treatment, as indicated by arrows in Figure  4 , cells with enhanced DCF¯uorescence and cells with lower and dierently distributed DiOC 6 (3)¯uorescence could be detected, their number increasing as a function of time. Moreover, these changes correlated with rounding up of the cell and nuclear condensation monitored with the DAPI¯uorescence. Although all cells with these morphological apoptotic features showed¯uorescence changes and all cells with lower DiOC 6 (3)¯uorescence harbored morphological modi®cations, there were some cells exhibiting an increase in DCF¯uorescence with intermediate alterations, i.e. with progressing morphological alteration but without nuclear condensation (Figure 4, arrowheads) . These observations show that the drops of the DCm are associated with the progress of morphological features that characterize apoptosis while the ®rst increase in ROS generation could constitute a primary event preceding the commitment to the cell death process.
ROS constitute mediators of one of the two TNF-a-activated signaling cascades
To further document the role of ROS in TNF-ainduced cytotoxicity, the scavenging of TNF-a-induced ROS by BHA, a potent anti-oxidant, was analysed together with its capacity to protect cells against TNFa-induced apoptosis. When BHA was added at the same time as TNF-a, ROS accumulation was greatly delayed and reduced (Figure 5b ) as was cell killing (Figure 1, photograph and histogram) . Moreover, the commitment to the cell death process observed in the presence of this anti-oxidant was ROS-independent: the loss of the DCm and the morphological changes occurred before an increase in ROS generation (Figure 5a compared to 5b) . However, under these conditions, the terminal phase of cell destruction was always associated with an accumulation of ROS that could not be scavenged by BHA. This observation suggests that ROS produced during the activation and the destruction phases are of dierent types. Taken together, these results support the idea that two separate signaling cascades are activated by TNF-a in HeLa cells, one ROS-dependent and the other ROSindependent. Moreover, the comparison of the kinetic and of the extent of cell death process in the presence TNF-a activates at least two apoptotic cascades C Sidoti-de Fraisse et al and in the absence of anti-oxidant suggests that the ROS-dependent pathway is nevertheless predominant and proceeds more rapidly that the other one (Figure 1 and 5a).
With the aim to assess the eect of ROS accumulation on cellular redox potential, we have measured the fate of the redox modulator glutathione (GSH) in E/TNF-treated HeLa cells. For this purpose,¯ow cytometric analysis were carried out using monobromobimane (mBBr) as speci®c probe. Cellular appearance of GS-mBBr¯uorescence was monitored and results obtained are depicted in Figure 6 . The intracellular GSH content of HeLa cells was observed to fall after exposure to E/TNF (Figure 6a ), the mean¯u orescence of mBBr-negative cells being three times less than that of control cells. The evolution of the percentage of mBBr-negative cell population (plotted in Figure 6b ) is correlated with the appearance of DCFpositive cells during E/TNF treatment (see Figure 5b) . When BHA was added at the same time as E/TNF, GSH depletion was greatly delayed and reduced, suggesting that ROS produced are responsible for GSH depletion.
Rho 0 HeLa cells are less sensitive to TNF-a-induced cytotoxicity
In order to investigate the involvement of mitochondria in the initial generation of ROS during TNF-ainduced cell death, we have isolated subclones of HeLa cells that are de®cient in a functional respiratory chain. Respiration de®ciency was generated by long-term culture of HeLa cells in ethidium bromide (EtB) containing medium, a procedure which has been repeatedly used to deplete cells of mitochondrial electron systems (Desjardins et al., 1985; King and Attardi, 1989) , as EtB has been described as a speci®c inhibitor of mitochondrial DNA (mtDNA) replication. Several subclones of EtB-resistant cells were isolated and controlled for mtDNA depletion (data not shown). Two rho 0 clones, namely B4 and B5, were retained for this study. Only results obtained with rho 0 B4 cell line are presented as both rho 0 clones gave similar responses. (Figure 7a ). Moreover, it should be noted that in rho 0 cells, ROS-accumulation took place after the loss of DCm and the onset of the cell death process, and was not scavenged by BHA (Figure 7c ). This ROS accumulation is in fact associated with the onset of the destruction phase and must correspond to the second burst described in rho + cells. Furthermore, addition of BHA has little or no eect on the kinetic and the extent of cell death (Figure 7b) . Therefore, activation of the TNF-ainduced apoptotic program in rho 0 cells does not require ROS production. In conclusion, as the ROSdependent pathway is not eective in rho 0 cells, it can be assumed that the production of ROS involved in the activation phase of this signaling cascade is dependent on the presence of a functional respiratory chain, indeed even that ROS are produced by mitochondria.
The two TNF-a-induced signaling cascades require an upstream activation of Z-VAD sensitive caspase(s) Several caspases have been assumed to mediate TNF-a cytotoxicity (Nagata, 1997) . Caspase-8 appears as an upstream component of the cell death signaling cascade leading to the activation of caspases-3 or -7 which would be part of the killing machinery (Beidler et al., 1995; Miura et al., 1995) . In order to compare the relative involvement of caspases in the two described TNF-a-activated transduction pathways in HeLa cells, we have investigated the relationship between caspases and the physiological and biochemical events of the TNF-a-induced apoptosis. For this purpose, we have analysed the eect of Z-VAD, a general caspase inhibitor on the morphological changes, the ROS production and the mitochondrial membrane potential loss observed during the E/TNF treatment of HeLa cells.
When Z-VAD was added to rho + HeLa cells at the same time as E/TNF, DCm loss and ROS accumulation were totally blocked (Figure 5a and b) as was cell shrinkage and cell killing (Figure 1, photograph and  histogram) . This result is in agreement with the substantial evidence implicating caspase-8, a Z-VAD sensitive caspase (Martin et al., 1998) , in a primary phase of the TNF-a-induced apoptosis (Miura et al., 1995) . Here, we show that activation of caspase(s) takes place upstream from the appearance of DCFmedium cells, i.e. in the activation phase of the ROSdependent pathway. That caspases are also involved in the activation phase of the ROS-independent signaling cascade was supported by the following observations: (i) DiOC 6 (3)-negative cells do not appear in the presence of Z-VAD while they appear after 4 h in the presence of BHA (Figure 5a ), where the ROSindependant pathway predominates; (ii) the protective eect against cell death is higher with Z-VAD than with BHA (Figure 1, photograph and histogram) ; (iii) Z-VAD inhibits cell death observed in the presence of BHA (data not shown) and (iv) Z-VAD could eciently protect rho 0 HeLa cells from loss of DCm and ROS production (Figure 7b and c) and from cell death (data not shown).
Discussion
TNF-a activates multiple apoptosis signaling pathways, one of which is mediated by ROS
In our study, we have investigated the role of ROS in TNF-a-induced PCD of HeLa cells. Indeed, TNF-atreatment of HeLa cells provoked the appearance of the characteristic morphological and molecular features of apoptosis. The kinetic study of the process allowed us to precisely de®ne three distinct phases: (i) the activation phase, during which no macroscopic changes could be observed; (ii) the execution phase, where the morphological apoptotic changes arise (rounding up and shrinkage of the cell, condensation and subsequent fragmentation of the chromatin, disruption of the cytoskeleton and blebbing of the plasma membrane) and lastly; (iii) the destruction phase characterized by the detachment, the loss of refringence of the cell and by the terminal fragmentation of nuclear DNA. In order to clarify the role of ROS in this apoptotic model, we have analysed with¯ow cytometry the production of intracellular ROS. This method revealed two`time-distinct' increases in ROS accumulation: the ®rst increase, that could be responsible for GSH depletion in our model, could be associated with the commitment of cells into the apoptotic process while the second one preceded the terminal phase of destruction of the cells. Moreover, epi¯uorescence microscopy examination showed that the ®rst observed ROS accumulation could be more precisely correlated with the activation phase of the cell death program. Hence, with the aim to clarify the contribution of ROS in this early phase, we tested the eect of the synthetic ROS scavenger BHA on the TNF-ainduced apoptosis. BHA delays and reduces the ®rst observed ROS accumulation and protects against TNF-a cytotoxicity. However, some cells nevertheless died in the presence of the anti-oxidant. These cells did not harbor this ®rst ROS production preceding the commitment to cell death but exhibited the morphological features of apoptosis. These results allow us to suggest that two separate transduction pathways are activated by TNF-a in HeLa cells, one involving ROS and the other ROS-independent. Moreover, it appears that the ROS-mediated signaling cascade is predominant and that it proceeds more rapidly than the ROSindependent pathway. To our knowledge, although ROS are clearly involved in TNF-a-induced necrosis this is the ®rst time that clear evidence of such a crucial role for ROS is established in TNF-a-induced apoptosis. These data could be related to the existence of a negative feedback mechanism associated with TNF-a-signaling in which NF-kB activation suppresses the signal for cell death (Beg and Baltimore, 1996; Liu et al., 1996b; Van Antwerp et al., 1996; Wang et al., 1996) . This protective eect was assumed to be linked to the induction of anti-apoptotic genes by NF-kB. Among the NF-kB-transcriptonally up-regulated genes, is the gene encoding the manganese superoxide dismutase, an enzyme that takes part in the antioxidant defense system developed by all aerobic cells. In relation with our data, it can be assumed that, in the presence of macromolecular synthesis inhibitors, the sensitivity of HeLa cells to TNF-a-induced cell killing would result from their inability to scavenge the increased ROS production triggered by the TNFR1 activation.
Our study also revealed the existence of a second step of ROS accumulation which appeared as a late event of the execution phase of the apoptotic process, just preceding the terminal destruction of the cell. This ROS production was observed in the rho + HeLa cells as well as in the rho 0 ones, suggesting that it occurs independently from the mitochondrial respiratory chain. This result can be linked to the following observations: (i) these compounds, unlike the activation phase ± associated ROS, are not scavenged by the synthetic BHA and; (ii) they can oxidize hydroethidine while the former do not (data not shown). Therefore, we can assume that the ROS produced during these two steps are of dierent types. The signi®cance of this secondary ROS increase in the TNF-a-induced apoptosis is unclear; indeed, it may correspond to a side eect of the process or, conversely, to a crucial event involved in the destruction of the cellular structures.
Functional mitochondria are required for the ROS-dependent signaling pathway
Another problem that we have approached in our study concerns the con¯icting question of the source of ROS mediating the TNF-a-induced cell death. Most investigators believe that oxidants are generated by the mitochondria as a result of an early alteration of the mitochondrial respiratory chain (Schulze-Ostho et al., 1993) . The protective eect exerted by inhibitors or by elimination of electron transport chain provide major arguments for this model. However, it was also suggested that fatty acid metabolites, such as those produced from arachidonic acid by the lipoxygenase pathway, rather than mitochondrial ROS, are messengers of the TNF-a-induced cytotoxicity (O'Donnell et al., 1995) .
We have assessed the role of mitochondria in the ROS-dependent signaling cascade, by examining the requirement of the mitochondial respiratory chain (the source of mitochondrial ROS production) in the TNFa-induced cell death pathway. For this purpose, we isolated mitochondrial DNA-depleted subclones of HeLa cells. The obtained rho 0 cells presented a TNF-a activates at least two apoptotic cascades C Sidoti-de Fraisse et al marked resistance towards TNF-a cytotoxicity which corresponded to an inhibition of the ROS-dependent signaling pathway while the ROS-independent one was always eective. While these cells showed a slightly dierent morphology and a reduced growth rate, they did not however reveal any signi®cant modi®cation of TNF-a receptor numbers as measured by Western blot using speci®c antibodies (data not shown). The existence of one mitochondrial respiratory chainindependent pathway would explain why some rho 0 cells are sensitive to TNF-a (Gamen et al., 1995; Marchetti et al., 1996) while others are not (Higuchi et al., 1997) . The ability of a rho 0 cell to undergo apoptosis would necessitate a functional ROS-independent pathway which could be cell type speci®c.
The resistance of rho 0 cells did not correlate with a more eective anti-oxidant defense system as ascertained by their higher sensitivity to externally applied hydrogen peroxide than their counterpart rho + cells (data not shown). Thus the acquired resistance of rho 0 cells to TNF-a treatment outlines the crucial role of mitochondria in the major TNF-a-induced killing pathway as the probable source of ROS involved in the activation phase of this process. However these results do not demonstrate that mitochondrial ROS are messengers of the death signaling cascade. An alternative explanation would consider that mitochondrial ROS or other mitochondria-derived intermediates could be required in the pathway that leads to the accumulation of ROS produced elsewhere. Thus, the mitochondrial ROS, which are usually generated in active mitochondria, could activate some metabolites that accumulate in response to the TNF-a treatment. The generation of the highly, reactive peroxinitrite provides a good example for this hypothesis, in the way that it results from the reaction between the mitochondria-produced superoxide anion and the cytoplasmic nitric oxide (Packer and Murphy, 1994) .
What is the mechanism leading to the accumulation of mitochondrial ROS? Much of the available data converge to the hypothesis that ROS increases are the consequence of an impairment of the mitochondrial respiratory chain (Schulze-Ostho et al., 1992; Gudz et al., 1997; Quillet-Mary et al., 1997; France-Lanord et al., 1997) . Indeed, it was shown that an upstream inhibition, with chemical compounds acting on complex I (Schulze-Ostho et al., 1992; Quillet-Mary et al., 1997), or an elimination of the electron transfer chain (Schulze-Ostho et al., 1993; Higuchi et al., 1997) , by depletion of the mtDNA, prevent ROS accumulation and consequently protect cells against PCD. The ubiquinone site in complex III appears as the major site of mitochondrial ROS production as this site catalyzes the conversion of molecular oxygen to superoxide anion which can lead to the formation of other potent ROS such as hydrogen peroxide and hydrogen radicals. Such a model is supported by the observed potentiation of cell death processes in ROSdependent PCD when electron¯ow was inhibited distal to the ubiquinone pool. In agreement with the above considerations, the observed alterations are distal to the ubiquinone site of the complex III, but the origin of these electron¯ow disturbances are not clear. The only strong evidence comes from the study of ceramide-induced PCD, in which an increased H 2 O 2 production was linked to mitochondrial Ca 2+ homeostasis perturbation as inhibition of the mitochondrial Ca 2+ uptake was shown to abolish both ROS accumulation and cell death (Gudz et al., 1997; Quillet-Mary et al., 1997; France-Lanord et al., 1997) . However, the recently observed shift of cytochrome c from mitochondria to cytosol in the early phases of many PCD (see below) could provide a clue to resolve this question (Liu et al., 1996a; Kluck et al., 1997; Yang et al., 1997) . Indeed, the release of cytochrome c must lead to a breakdown of the mitochondrial electron¯ow downstream of the ubiquinone site which in turn would result in an increased generation of ROS. Such a model is supported by the described correlation between loss of cytochrome c in respiratory failure in a Fas-induced PCD model (Krippner et al., 1996) .
Caspases are the core components of the two TNF-a-induced signaling cascades
We have shown that Z-VAD-sensitive caspase(s) are involved in the early stages of the apoptotic program leading to the activation of the execution machinery. Moreover, these caspases constitute part of the two, ROS-dependent and ROS-independent, cell death signaling pathways that we have shown to be activated by TNF-a in the rho + HeLa cells. According to the protein recruitment model for TNF-a killing, this activity would correspond to caspase-8 whose recruitment to the cytoplasmic domain of TNFR1 allows its autoactivation and initiates a protease cascade leading to dismantlement of the cell (Nagata, 1997) . This hypothesis is reinforced by the elsewhere described sensitivity of caspase-8 to Z-VAD (Martin et al., 1998) . How can the existence of two pathways similarly sensitive to the Z-VAD inhibitor be integrated in this model? One possibility is that the two TNF-a-induced transduction cascades diverge downstream of caspase-8 and correspond to the activation by proteolytic cleavage of components able to activate by dierent routes the executors of the apoptotic program. Protein kinases, sphingomyelinases or phospholipases that have been shown to be activated in response to TNF-a could be potential targets for caspase-8 and mediators of the death signal. A second possibility is that TNF-a triggers two apoptotic pathways that diverge from the cytoplasmic domain of TNFR1, in relation with the FADD-and RIP-mediated recruitment of distinct death eector molecules. These two routes, one leading to ROS production and the other one not, would involve distinct caspases, namely caspase-8 and caspase-2. However, the observations that dominant negative FADD (Chinnaiyan et al., 1995) or MACH (Boldin et al., 1996) can completely inhibit apoptosis make this second model uncertain. Recently, such à two signaling pathways' model has been described in CD95-mediated PCD (Scadi et al., 1998) , suggesting that this phenomenon could be a general feature of apoptosis induced via the transmembrane receptors of the TNF family (Nagata, 1997) .
Furthermore, the ®nding that ROS play a crucial role in the transduction of the death signal downstream of the TNFR1-recruited caspase(s) during the initial phase impede the model of pro-apoptotic protease cascade where caspases are presumed to exist within hierarchies of auto-and trans-cleavage (Fraser and Evan, 1996) . Our results suggest the existence of at least one more indirect, ROS-dependent, mechanism for the activation of the execution caspases which constitute the core of the killing machinery. This observation is consistent with the observed caspaseindependent activation of execution machinery (caspase-3) in many diversely triggered PCD (McCarthy, et al., 1997) , and allow us to propose that the proteases cascade would not be the predominant way to activate the executor caspases.
Role of ROS in cell death signaling
The involvement of mitochondrial ROS in cell death transduction pathway leads to the fundamental questions concerning the molecular mechanisms underlying the ROS signaling, in particular how ROS mediate activation caspases of the cell death machinery. Two models can be proposed to approach this con¯icting and not well documented subject. The ®rst model assumes that ROS themselves are signaling molecules which activate some crucial components of the PCD machinery. Conversely, the alternative proposition suggests that ROS can act indirectly by modifying the cellular redox potential, which would regulate some key regulatory proteins involved in PCD. Note that the observations that we have made in TNF-a-induced killing of HeLa cells suggest that ROS produced provoke an oxidative stress via GSH depletion. Several lines of evidence con®rmed by much of the available data agree with an explanation based on indirectly mediated action. First, unlike fatty acid metabolites which harbor speci®c reactivity and are known to mediate particular signals from surface receptors, mitochondrial ROS are characterized by a lack of biological speci®city or even an extreme reactivity, as for the hydroxyl radical: these are all features contrary to the requirement of a speci®c signaling role (Jacobson, 1996) . In this way, a direct in¯uence of ROS on PCD process would be correlated to a general damaging eect on cellular structures resulting in necrotic cell death, or perhaps to a more limited action on mitochondria, their site of production, which in turn could activate some mitochondriadependent downstream cascades leading to PCD. Secondly, despite the compelling evidence on the role of mitochondrial ROS in PCD signaling pathways, the prevalent idea is nevertheless that they do not represent a general mediator of cell death, as suggested by the ability of some PCD to occur in very low oxygen environments (Jacobson and Ra, 1995; Shimizu et al., 1995) . However, an alternative approach to this problem would be to consider that the major eect of an increased ROS production is the subsequent decreased availibility of intracellular anti-oxidants as NADH, NADPH or glutathione, leading to imbalance of redox status which would be the central common eector of PCD. Anti-Fas/APO-1 antibody or interleukin-3 (IL-3) withdrawal-induced PCD represent good illustrations of this model (van den Dobbelsteen et al., 1996; Bojes et al., 1997) . Indeed, no ROS accumulation can be measured in these two systems and anareobic cultured cells deprived of IL-3 still undergo PCD (Schulze-Ostho et al., 1994; Shimizu et al., 1995) . However, an oxidative stress can be shown in these models with a depletion of glutathione resulting from its rapid and speci®c eux. This event takes place at the very beginning of the apoptoptic process (van den Dobbelsteen et al., 1996; Bojes et al., 1997) . Moreover, it has been shown that Bcl-2 can protect cells from PCD by shifting the cellular redox potential to a more reduced state (Ellerby et al., 1996) . However, the observation that oxidation of thiols other than glutathione can mediate induction of PCD suggest that the intracellular thiol redox status would be the real key factor of the cell death signaling pathways (Kane et al., 1993; Sato et al., 1995; Marchetti et al., 1997; Mirkovic et al., 1997) . In this model, the redox state of glutathione or other cellular anti-oxidants such as thioredoxine, would be in equilibrium with that of thiols resident in some redox sensitive crucial components of the execution machinery as execution caspases Mignotte and VayssieÁ re, 1998) . Where does ROS ®t this thiol hypothesis? In this putative model, an increased production of mitochondrial ROS would result, either by a direct modi®cation of the thiols or indirectly via a depletion of the intracellular anti-oxidant pool, in a shift of the redox state of the sensor SH groups to a more oxidized state. The nature of the ROS and the level of the intracellular anti-oxidant defenses would determine in which way regulatory components are activated to commit cells to PCD.
Conclusions
In conclusion, we have shown that binding of TNF-a to TNFR1 triggers multiple death signaling cascades, one of which being mediated by ROS, that nevertheless converge to a common apoptotic cell death (Figure 8 ). Each one of these pathways involves an early activation of Z-VAD-sensitive caspase(s), which regulate downstream the engagement of the execution process. Finally, our results also help to de®ne the exact importance of mitochondria in the TNF-ainduced cell death process. Indeed, we show on the one hand that mitochondria play a key role in the ROS-dependent signaling pathway and, on the other hand, that mitochondrial membrane depolarization constitutes a caspase-dependent event of the execution stage which could then determine the downstream progress of the cell death program.
Materials and methods
Reagents 3,3'-diethyloxacarbocyanine (DiOC 6 (3)), monobromobimane (mBBr) and dichloro¯uorescin diacetate (DCFH-DA) were purchased from Molecular Probes (Eugene, OR, USA). Butylated hydroxyanisole (BHA), propidium iodide (PI), diamidino phenylindole (DAPI), recombinant TNF-a (2610 7 units/mg) were from Sigma (St Louis, Mo, USA). Stock solutions of BHA, DCFH-DA, mBBr and DiOC 6 (3) were prepared in ethanol. DAPI, PI and TNF-a were dissolved in water. Z-Val-Ala-DL-Asp-Fluoromethylketone (Z-VAD) was from Bachem (Bubendorf, Switzerland) and was prepared in methanol. All stock solutions were stored at 7208C.
Cell culture and induction of cell death
HeLa S3 cells were propagated at 378C in a humidi®ed atmosphere containing 5% CO 2 in DMEM/F12 medium supplemented with 10% FCS plus penicillin (100 mg/ml), streptomycin (100 U/ml), 4.5 mg/ml glucose, 50 mg/ml sodium pyruvate and 100 mg/ml uridine.
To deplete mitochondrial DNA (mtDNA), HeLa cells were grown during 2 months in the presence of 0.2 mg/ml ethidium bromide (EtB). Several sublines were isolated and checked for mtDNA depletion using a speci®c PCR. Two clones of HeLa cells lacking mtDNA (rho 0 ) were obtained (named clones B4 and B5). Cells lacking mtDNA were auxotrophic for uridine and pyruvate (King and Attardi, 1989) . Therefore, both rho 0 and control cells were maintained in standard medium supplemented with pyruvate and uridine, The cultures were screened regularly for the absence of mycoplasma by a DNA-¯uorochrome assay.
Cell death was induced by addition of TNF-a (5 ng/ml) plus emetine (1 mg/ml) on exponentially growing adherent cells. Cells treated with emetine alone or with TNF-a alone were used as controls.
Flow cytometric analysis
Mitochondrial membrane potential, ROS production and glutathione Mitochondrial membrane potential was assessed by the retention of DiOC 6 (3). The cationic lipophilic uorochrome DiOC 6 (3) is a cell permeable marker that, at low doses (0.1 mM), speci®cally accumulates into mitochondria depending on mitochondrial membrane potential (Petit et al., 1990) . ROS generation was measured by the production of dichloro¯uorescein (DCF) derived from oxidization of DCFH. DCFH-DA is a¯uorogenic freely permeable tracer speci®c for ROS assessment. DCFH-DA is deacetylated by intracellular esterases to the nonfluorescent compound DCFH, which is oxidized to thē uorescent compound DCF by a variety of peroxides, including hydrogen peroxide. Intracellular reduced glutathione (GSH) level was assessed using a speci®c probe, monobromobimane (mBBr). The cell permeant mBBr probe is non-¯uorescent but forms a¯uorescent adduct with GSH (GS-mBBr) in a nonenzymatic reaction. Plasma membrane integrity was examinated by PI exclusion from the cell compartment.
Cell stainings were performed as follows: cells were harvested at dierent time points of the emetine plus TNFa (E/TNF) treatment, centrifuged and resuspended in complete medium at a concentration of 10 6 cells/ml. Cells were then loaded either with DiOC 6 (3) (0.1 mM), or DCFH-DA (20 mM) for 30 min or with mBBr (50 mM) for 10 min. Labellings were processed at 378C in a humidi®ed 5% CO 2 / 95% air incubator. Prior to¯ow cytometric analysis, all samples were incubated with PI (10 mg/ml) for 5 min at 48C.
Flow cytometric measurements Flow cytometric measurements were performed on a ELITE ESP¯ow cytometer (Coulter 1 , France). Fluorescence excitation was obtained through the blue line (488 nm) of an argon ion laser operating at 15 mW. Green¯uorescence of DiOC 6 (3) or DCF was collected with a 525 nm band pass ®lter and red uorescence of PI with a 610 nm band pass ®lter. A 100 mW UV excitation (356 nm) from a Coherent laser (INOVA 305) was used for quanti®cation of GS-mBBr uorescence integrated above 457 nm. Analyses were performed on 10 4 cells and data were stored in listmode. Light scatter values were measured on a linear scale of 1024 channels and¯uorescence intensities on a logarithmic scale of¯uorescence of four decades of log.
In vivo¯uorescent measurement of ROS and mitochondrial transmembrane potential Cells were seeded on glass coverslips. E/TNF or emetine alone was added and at appropriate time points, cells were loaded with DiOC 6 (3) (0.1 mM) or DCFH-DA (20 mM) and DAPI (1 mg/ml) for 30 min at 378C. DAPI was used to estimate the nuclear condensation. After loading, the coverslips were disposed on a slide chamber containing fresh medium without drug and cells were then immediately examined by epi¯uorescence and photographed under a DMRB Leica microscope.
Abbreviations DCm, mitochondrial membrane potential; BHA, butylated hydroxyanisole; DAPI, diamidino phenylindole; DCF, dichloro¯uorescein; DCFH-DA, dichloro¯uorescin diacetate; DiOC 6 (3), 3,3'-diethyloxacarbocyanine; E/TNF, emetine/TNF-a; EtB, ethidium bromide; FSC, forward angle scatter; GSH, glutathione; mBBr, monobromobimane; mtDNA, mitochondrial DNA; PCD, programmed cell death; PI, propidium iodide; ROS, reactive oxygen species; SSC, side angle scatter; TNF-a, tumor necrosis factor-a; Z-VAD, Z-Val-Ala-DL-Asp-¯uoromethylketone.
